Cargando…

Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) is a highly prevalent but still poorly understood clinical entity. Its current pathophysiological understanding supports a critical role of comorbidities and their chronic effect on cardiac function and structure. Importantly, despite the replic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sebastião, Maria J., Almeida, Henrique V., Serra, Margarida, Hamdani, Nazha, Saraiva, Francisca, Lourenço, André P., Barros, António S., Vasques-Nóvoa, Francisco, Leite-Moreira, Adelino, Alves, Paula M., Falcão-Pires, Inês, Gomes-Alves, Patrícia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687619/ https://www.ncbi.nlm.nih.gov/pubmed/36428511 http://dx.doi.org/10.3390/biomedicines10112943

Ejemplares similares

Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
por: van Heerebeek, Loek, et al.
Publicado: (2013)

Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
por: Inácio, José M., et al.
Publicado: (2023)

Thyroid hormones and modulation of diastolic function: a promising target for heart failure with preserved ejection fraction
por: Neves, João Sérgio, et al.
Publicado: (2020)

Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
por: Vaz-Salvador, Pedro, et al.
Publicado: (2022)

Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
por: Budde, Heidi, et al.
Publicado: (2022)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy
por: Trindade, Fábio, et al.
Publicado: (2020)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

OR19-2 Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) with Low and High Dose of Triiodothyronine: an Animal Model of Metabolic Syndrome with HFpEF
por: Almeida-Coelho, João, et al.
Publicado: (2022)

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
por: Neves, João Sérgio, et al.
Publicado: (2022)

Assessing the influence of perfusion on cardiac microtissue maturation: A heart‐on‐chip platform embedding peristaltic pump capabilities
por: Cruz‐Moreira, Daniela, et al.
Publicado: (2021)

Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk‐related rat model of heart failure with preserved ejection fraction
por: Miranda‐Silva, Daniela, et al.
Publicado: (2019)

Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload
por: Miranda-Silva, Daniela, et al.
Publicado: (2019)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020)

Gender Differences in Predictors and Long-Term Mortality of New-Onset Postoperative Atrial Fibrillation Following Isolated Aortic Valve Replacement Surgery
por: Fragão-Marques, Mariana, et al.
Publicado: (2020)

Optimization of a Protocol for Protein Extraction from Calcified Aortic Valves for Proteomics Applications: Development of a Standard Operating Procedure
por: Trindade, Fábio, et al.
Publicado: (2022)

Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
por: van der Velden, Jolanda, et al.
Publicado: (2018)

Pericardial Fluid Annexin A1 Is a Marker of Atrial Fibrillation in Aortic Stenosis: A Proteomics Analysis
por: Fragão-Marques, Mariana, et al.
Publicado: (2022)

Body mass index effect on long-term survival after coronary artery bypass surgery: a competing risk analysis
por: Abreu, Armando, et al.
Publicado: (2023)

Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Unraveling the Role of Epicardial Adipose Tissue in Coronary Artery Disease: Partners in Crime?
por: Conceição, Glória, et al.
Publicado: (2020)

Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats
por: Zhazykbayeva, Saltanat, et al.
Publicado: (2023)

Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis
por: Fragão-Marques, Mariana, et al.
Publicado: (2021)

Mining the Biomarker Potential of the Urine Peptidome: From Amino Acids Properties to Proteases
por: Trindade, Fábio, et al.
Publicado: (2021)

Coronary Artery Disease and Aortic Valve Stenosis: A Urine Proteomics Study
por: Perpétuo, Luís, et al.
Publicado: (2022)

Alterações da Rigidez Arterial em Pacientes com Estenose Aórtica Grave Submetidos à Cirurgia de Troca Valvar
por: Raimundo, Renata, et al.
Publicado: (2021)

The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC
por: Frantz, Stefan, et al.
Publicado: (2018)

The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta‐analysis
por: Leite, Marta, et al.
Publicado: (2023)

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
por: Kovács, Á., et al.
Publicado: (2016)

Increased Transglutaminase 2 Expression and Activity in Rodent Models of Obesity/Metabolic Syndrome and Aging
por: Penumatsa, Krishna C., et al.
Publicado: (2020)

Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Unveiling an oral hemangiolymphangioma
por: Ferreira-Santos, Rívea Inês, et al.
Publicado: (2023)

Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates
por: Tavares‐Silva, Marta, et al.
Publicado: (2021)

Myocardial oedema: pathophysiological basis and implications for the failing heart
por: Vasques‐Nóvoa, Francisco, et al.
Publicado: (2022)

Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis
por: Mancio, Jennifer, et al.
Publicado: (2017)

Bioinformatic Approach to Unveil Key Differentially Expressed Proteins in Human Sperm After Slow and Rapid Cryopreservation
por: Corda, Pedro O., et al.
Publicado: (2022)

MON-587 Thyroid Hormones within the Normal Range and Cardiac Function in the General Population: The Epiporto Study
por: Neves, João Sérgio, et al.
Publicado: (2019)

Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study
por: Lima, Tânia, et al.
Publicado: (2022)

Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
por: Lima, Tânia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j4faq5pngedjmlt33lb1j293t5